Dr. Greg Licholai
Chief Medical Officer
Dr. Greg Licholai is Chief Medical Officer (CMO) at Syneos Health®, where he leads the Company’s global medical and scientific strategic functions, advancing innovative, technology-enabled solutions that accelerate drug development and improve patient outcomes. A physician, trained neurosurgeon, life science executive and entrepreneur associated with multiple successful innovations, he has guided companies through critical inflection points. From early development through commercialization, he has a unique understanding of how scientific, operational and market decisions intersect to drive outcomes.
Dr. Licholai has led innovation across notable industry organizations, including serving as Chief Medical and Innovation Officer at ICON and President of Rare Disease at Moderna. He has also built and advised biotechnology companies and was a partner at McKinsey & Company. In addition, Dr. Licholai is on the faculty at the Yale School of Management, has taught at Harvard Business School and holds board roles with several nonprofit and patient organizations – reflecting a career at the intersection of science, business and innovation.
He holds an MD from Yale School of Medicine, an MBA from Harvard Business School and attended Columbia University for pre-medical studies.
